JP2006512097A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006512097A5 JP2006512097A5 JP2005510053A JP2005510053A JP2006512097A5 JP 2006512097 A5 JP2006512097 A5 JP 2006512097A5 JP 2005510053 A JP2005510053 A JP 2005510053A JP 2005510053 A JP2005510053 A JP 2005510053A JP 2006512097 A5 JP2006512097 A5 JP 2006512097A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- nucleic acid
- ctla
- acid sequence
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43626802P | 2002-12-23 | 2002-12-23 | |
| US46660703P | 2003-04-30 | 2003-04-30 | |
| PCT/US2003/041053 WO2004058801A2 (en) | 2002-12-23 | 2003-12-22 | Modified vaccinia ankara expressing p53 in cancer immunotherapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006512097A JP2006512097A (ja) | 2006-04-13 |
| JP2006512097A5 true JP2006512097A5 (https=) | 2007-02-15 |
Family
ID=32685446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005510053A Withdrawn JP2006512097A (ja) | 2002-12-23 | 2003-12-22 | 癌免疫療法におけるｐ５３を発現する改変・ワクシニア・アンカラ |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7256037B2 (https=) |
| EP (1) | EP1575611A4 (https=) |
| JP (1) | JP2006512097A (https=) |
| AU (1) | AU2003297499A1 (https=) |
| CA (1) | CA2511625A1 (https=) |
| WO (1) | WO2004058801A2 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10100316B2 (en) * | 2002-11-21 | 2018-10-16 | Archemix Llc | Aptamers comprising CPG motifs |
| US20060246123A1 (en) * | 2003-03-12 | 2006-11-02 | Eli Gilboa | Oligonucleotide mimetics |
| US7674456B2 (en) * | 2004-06-14 | 2010-03-09 | Charles Wiseman | Breast cancer cell lines and uses thereof |
| UA100836C2 (ru) | 2005-02-23 | 2013-02-11 | Бавариан Нордик А/С | Применение модифицированного вируса осповакцины анкара (mva) для быстрой индукции иммунитета против поксвирусных или других инфекционных агентов |
| KR20080030656A (ko) * | 2005-07-07 | 2008-04-04 | 콜레이 파마시티컬 그룹, 인코포레이티드 | 암 치료를 위한 항-ＣＴＬＡ-4 항체 및 ＣｐＧ-모티프-함유합성 올리고데옥시뉴클레오티드의 조합 요법 |
| CN1919873B (zh) * | 2005-08-25 | 2012-05-30 | 北京沙东生物技术有限公司 | 包含人HSP70 ATPase结构域与哺乳动物p53蛋白的融合蛋白及其应用 |
| WO2007123737A2 (en) * | 2006-03-30 | 2007-11-01 | University Of California | Methods and compositions for localized secretion of anti-ctla-4 antibodies |
| JP5331105B2 (ja) * | 2007-05-24 | 2013-10-30 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 凍結乾燥抗原組成物 |
| US7998488B2 (en) * | 2008-11-14 | 2011-08-16 | Baxter International Inc. | Vaccine formulations and uses thereof |
| WO2015077717A1 (en) | 2013-11-25 | 2015-05-28 | The Broad Institute Inc. | Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status |
| WO2015085147A1 (en) | 2013-12-05 | 2015-06-11 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
| KR20230076867A (ko) | 2013-12-20 | 2023-05-31 | 더 브로드 인스티튜트, 인코퍼레이티드 | 신생항원 백신과의 병용 요법 |
| US10975442B2 (en) | 2014-12-19 | 2021-04-13 | Massachusetts Institute Of Technology | Molecular biomarkers for cancer immunotherapy |
| EP3234130B1 (en) | 2014-12-19 | 2020-11-25 | The Broad Institute, Inc. | Methods for profiling the t-cell- receptor repertoire |
| EP4523756A3 (en) | 2015-02-13 | 2025-05-28 | Transgene | Immunotherapeutic vaccine and antibody combination therapy |
| CN115300622A (zh) * | 2015-02-25 | 2022-11-08 | 纪念斯隆-凯特琳癌症中心 | 使用灭活的修饰的痘苗病毒安卡拉作为实体肿瘤的单一免疫疗法或与免疫检查点阻断剂组合 |
| CN107847534B (zh) * | 2015-04-17 | 2022-10-04 | 纪念斯隆凯特琳癌症中心 | Mva或mvaδe3l作为抗实体瘤的免疫治疗剂的应用 |
| IL294183B2 (en) | 2015-05-20 | 2023-10-01 | Dana Farber Cancer Inst Inc | shared neoantigens |
| WO2017079746A2 (en) | 2015-11-07 | 2017-05-11 | Multivir Inc. | Methods and compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer |
| IL261321B2 (en) | 2016-02-25 | 2023-12-01 | Memorial Sloan Kettering Cancer Center | Recombinant mva or mvadele3l expressing human flt3l and use thereof as immuno-therapeutic agents against solid tumors |
| KR20180133395A (ko) | 2016-02-25 | 2018-12-14 | 메모리얼 슬로안 케터링 캔서 센터 | 암 면역요법을 위한, 인간 flt3l 또는 gm-csf의 발현이 있거나 없으며 티미딘 키나제가 결실된 복제 가능 약독화 백시니아 바이러스 |
| WO2018107011A1 (en) * | 2016-12-08 | 2018-06-14 | City Of Hope | P53-targeting vaccines and pd-1 pathway inhibitors and methods of use thereof |
| KR20190112263A (ko) | 2016-12-12 | 2019-10-04 | 멀티비르 인코포레이티드 | 암 및 감염성 질환의 치료 및 예방을 위한 바이러스 유전자 치료요법 및 면역 체크포인트 억제제를 포함하는 방법 및 조성물 |
| WO2018112470A1 (en) * | 2016-12-16 | 2018-06-21 | The Brigham And Women's Hospital, Inc. | Co-delivery of nucleic acids for simultaneous suppression and expression of target genes |
| US11549149B2 (en) | 2017-01-24 | 2023-01-10 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
| WO2018209315A1 (en) | 2017-05-12 | 2018-11-15 | Memorial Sloan Kettering Cancer Center | Vaccinia virus mutants useful for cancer immunotherapy |
| US20210177964A1 (en) * | 2017-11-06 | 2021-06-17 | Memorial Sloan Kettering Cancer Center | Heat-inactivated vaccinia virus as a vaccine immune adjuvant |
| WO2020036635A2 (en) | 2018-03-19 | 2020-02-20 | Multivir Inc. | Methods and compositions comprising tumor suppressor gene therapy and cd122/cd132 agonists for the treatment of cancer |
| MX2021003013A (es) | 2018-09-15 | 2021-08-11 | Memorial Sloan Kettering Cancer Center | Poxvirus recombinantes para inmunoterapia contra cáncer. |
| US12274784B2 (en) | 2018-10-12 | 2025-04-15 | Synergene Therapeutics, Inc. | Methods for reducing side effects of immunotherapy |
| WO2021113644A1 (en) | 2019-12-05 | 2021-06-10 | Multivir Inc. | Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer |
| WO2021262484A1 (en) * | 2020-06-24 | 2021-12-30 | Pmv Pharmaceuticals, Inc. | Combination therapy for treatment of cancer |
| CN115537399B (zh) * | 2022-09-22 | 2025-02-11 | 沈阳药科大学 | 修饰化外泌体及其制法和外泌体联合pd-1抗体的原位喷雾水凝胶和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1341245C (en) * | 1988-01-12 | 2001-06-05 | F. Hoffmann-La Roche Ag | Recombinant vaccinia virus mva |
| US6410010B1 (en) * | 1992-10-13 | 2002-06-25 | Board Of Regents, The University Of Texas System | Recombinant P53 adenovirus compositions |
| US6045802A (en) * | 1994-10-03 | 2000-04-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule |
| ATE403005T1 (de) * | 2003-02-18 | 2008-08-15 | Helmholtz Zentrum Muenchen | Rekombinantes mva und verfahren zur erzeugung davon |
-
2003
- 2003-12-22 CA CA002511625A patent/CA2511625A1/en not_active Abandoned
- 2003-12-22 WO PCT/US2003/041053 patent/WO2004058801A2/en not_active Ceased
- 2003-12-22 EP EP03814346A patent/EP1575611A4/en not_active Withdrawn
- 2003-12-22 AU AU2003297499A patent/AU2003297499A1/en not_active Abandoned
- 2003-12-22 JP JP2005510053A patent/JP2006512097A/ja not_active Withdrawn
- 2003-12-23 US US10/746,558 patent/US7256037B2/en not_active Expired - Lifetime
-
2007
- 2007-05-21 US US11/805,180 patent/US7563448B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006512097A5 (https=) | ||
| KR100767554B1 (ko) | 암 억제 유전자 더블유티1의 생산물에 기초한 암항원 | |
| RU2016109939A (ru) | Способ повышения экспрессии кодируемых рнк белков | |
| JP2008539187A5 (https=) | ||
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| US11478544B2 (en) | Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines contaning hepatitis B virus genes | |
| JP2002542827A5 (https=) | ||
| HRP20201873T1 (hr) | Sredstva i postupci za liječenje hbv-a | |
| KR20180038465A (ko) | Ｂ형 간염 바이러스 감염에 대한 ｒｎａｉ 치료법 | |
| TW201408309A (zh) | 用於治療ｂ型肝炎及ｄ型肝炎感染之方法 | |
| JP2008543890A5 (https=) | ||
| WO2014063601A1 (zh) | 诱导肿瘤特异性免疫的疫苗及其应用 | |
| WO2004085645A1 (en) | Rna interference in fish | |
| JP4261439B2 (ja) | 免疫調節能力の増加されたＣｐＧオリゴデオキシヌクレオチド変形体 | |
| JP2003530872A5 (https=) | ||
| MY209484A (en) | Cpg amphiphiles and uses thereof | |
| WO2018232353A4 (en) | Bacterial vaccine | |
| RU2004134331A (ru) | Антиген muc1 со сниженным числом повторяющихся vntr-блоков | |
| WO2003051454A3 (en) | Methods for particle-assisted polynucleotide immunization using a pulsed electric field | |
| WO2003031469A2 (de) | Mittel zur verbesserung der immunantwort | |
| JP2025067901A (ja) | 重症熱性血小板減少症候群ウイルスに対する新規ワクチン | |
| CN102000330B (zh) | 一种核酸疫苗佐剂及其构建方法 | |
| WO2015042187A1 (en) | Treatment of hepatitis d virus infections by redirection of t cells | |
| KR101329348B1 (ko) | 돼지 인터페론 알파-돼지 인터페론 감마를 동시 발현하는 재조합 아데노바이러스 | |
| RU98112608A (ru) | Иммуногенная композиция [на основе] tlp |